立即注册找回密码

QQ登录

只需一步,快速开始

微信登录

微信扫一扫,快速登录

手机动态码快速登录

手机号快速注册登录

搜索

图文播报

查看: 30102|回复: 0

[分享] The Covid-19 antibody test challengeCOVID-19试剂盒开发面临的调整

[复制链接]
发表于 2021-6-17 14:18 | 显示全部楼层 |阅读模式

登陆有奖并可浏览互动!

您需要 登录 才可以下载或查看,没有账号?立即注册 微信登录 手机动态码快速登录

×
In the current situation of the Covid-19 pandemic, reliable IgG antibody tests are urgently needed all around the world. Virologists caution against cross-reactivities that could potentially lead to false positives [1,2]. Using ELISAs as an example, we discuss the technical requirements for the development of truly dependable immunological testing methods, since the cross-reactivities debated by many virologists constitute only a small fraction of the actual challenges.


Known causes for “cross-reactivities” and false-positives


Four different causes for false-positives in serological assays are known:


1.Inappropriate capture antigens
2.Cross -reactivities and biochemical interferences
3.Insufficient surface blocking in serological assays
4.Stability of the reagents


如何解决此类问题,完整资料阅读:The Covid-19 antibody test challengeCOVID-1

楼主热帖
回复

使用道具 举报

发表回复

您需要登录后才可以回帖 登录 | 立即注册 微信登录 手机动态码快速登录

本版积分规则

关闭

官方推荐 上一条 /3 下一条

快速回复 返回列表 客服中心 搜索 官方QQ群 洽谈合作
快速回复返回顶部 返回列表